Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / The Genetic Switch in Pancreatic Cancer
Oncology Genetics and epigenetics Research and Innovations Molecular Pathology

The Genetic Switch in Pancreatic Cancer 

New research explains how a common cancer gene alters tumor type and may influence treatment response

03/13/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Oncology - Pancreatic Cancer Genetics and Molecular Biology

Leading institutions utilize integrated molecular biology, genomics, and translational research approaches to elucidate genetic pathways like KRAS and GATA6 in pancreatic cancer, combining laboratory experiments with clinical trials to develop targeted therapies.

  • #1

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC is a global leader in pancreatic cancer research with extensive expertise in KRAS-driven tumor biology and translational clinical trials targeting molecular pathways.

    Key Differentiators

    • Oncology
    • Molecular Genetics
    • Pancreatic Cancer Research
  • #2

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins has pioneered molecular classification of pancreatic cancer subtypes and studies on KRAS signaling pathways influencing tumor behavior and treatment response.

    Key Differentiators

    • Oncology
    • Molecular Oncology
    • Pancreatic Cancer
  • #3

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber is recognized for its cutting-edge research on oncogenic KRAS pathways and development of novel targeted therapies in pancreatic cancer.

    Key Differentiators

    • Cancer Biology
    • Molecular Therapeutics
    • Pancreatic Cancer
  • #4

    University of Texas MD Anderson Cancer Center

    Houston, TX

    MD Anderson has a robust pancreatic cancer program emphasizing molecular genetics and personalized medicine approaches targeting KRAS-driven tumor biology.

    Key Differentiators

    • Oncology
    • Molecular Cancer Research
    • Pancreatic Cancer
  • #5

    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    UCSF is known for its integrative research on pancreatic cancer molecular subtypes and the impact of KRAS signaling on tumor differentiation and therapy response.

    Key Differentiators

    • Cancer Biology
    • Translational Oncology
    • Pancreatic Cancer

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.